Prosecution Insights
Last updated: April 19, 2026

BEAM THERAPEUTICS INC.

5 pending office actions • 1 client

Portfolio Summary

5
Total Pending OAs
0
Final Rejections
5
Non-Final OAs

Client Portfolio (1 client)

Client (Assignee)Pending OAs
BEAM THERAPEUTICS INC. 5

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18746791 NANOMATERIALS COMPRISING TETRAVALENT LIPID COMPOUNDS BEAM THERAPEUTICS INC. BAEK, BONG-SOOK 1611 Non-Final OA Jun 18, 2024
18746810 IONIZABLE AMINE LIPIDS AND LIPID NANOPARTICLES BEAM THERAPEUTICS INC. SONG, JIANFENG 1613 Non-Final OA Jun 18, 2024
18220874 IONIZABLE LIPIDS FOR NANOMATERIALS BEAM THERAPEUTICS INC. MOORE, SUSANNA 1624 Non-Final OA Jul 12, 2023
18220867 NANOMATERIALS COMPRISING AN IONIZABLE LIPID BEAM THERAPEUTICS INC. SHTERENGARTS, SAMANTHA L 1623 Non-Final OA Jul 12, 2023
18211840 NANOMATERIALS COMPRISING CARBONATES BEAM THERAPEUTICS INC. PATEL, SAGAR S 1626 Non-Final OA Jun 20, 2023

Managing BEAM THERAPEUTICS INC.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month